Duration of therapy of cost-subsidised phentermine and topiramate in patients with obesity: A retrospective medical records audit of an Australian single site.

Autor: Houssarini JA; Royal Prince Alfred Hospital, Sydney, Australia; Central Clinical School, University of Sydney, Sydney, Australia., Franklin J; Royal Prince Alfred Hospital, Sydney, Australia; Central Clinical School, University of Sydney, Sydney, Australia., Markovic T; Royal Prince Alfred Hospital, Sydney, Australia; Central Clinical School, University of Sydney, Sydney, Australia; Boden Initiative, Charles Perkins Centre, University of Sydney, Sydney, Australia., Hocking SL; Royal Prince Alfred Hospital, Sydney, Australia; Central Clinical School, University of Sydney, Sydney, Australia; Boden Initiative, Charles Perkins Centre, University of Sydney, Sydney, Australia. Electronic address: samantha.hocking@sydney.edu.au.
Jazyk: angličtina
Zdroj: Obesity research & clinical practice [Obes Res Clin Pract] 2024 Jan-Feb; Vol. 18 (1), pp. 73-75. Date of Electronic Publication: 2024 Feb 15.
DOI: 10.1016/j.orcp.2024.01.005
Abstrakt: Competing Interests: Declaration of Competing Interest J.A.H has no interests to declare. J.F has received honoraria from Novo Nordisk. T.M. is on the Australian Nestle Health Science, VLCD Advisory Board. S.L.H. has received honoraria from iNova Pharmaceuticals, Eli Lilly and Novo Nordisk.
Databáze: MEDLINE
Externí odkaz: